Mangoceuticals Brand MangoRx Announced as Raindance Film Festival’s Headline Sponsor
Dallas, Texas, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” today announced it will be the headline sponsor for the thirty-first edition of the Raindance Film Festival, the UK’s leading indie film festival. Raindance returns to the heart of London’s West End from October 25 through November 4, 2023.
- As the headline sponsor of the 2023 festival, MangoRx will have a strong presence throughout the festival’s various programming including an orange carpet takeover at all celebrity carpet events, a MangoRx 60-second short film competition, hosted panels from Mango’s’ team of experts, and even a signature MangoRx themed cocktail.
- Through its partnership with Raindance, MangoRx increases awareness around sexual health in film and helps remove the stigma around erectile dysfunction.
- MangoRx will host a new 60-second short film competition, with short filmmakers challenged to focus on mental health and its connection to ED.
- I’m also excited that Raindance is challenging short filmmakers to focus on mental health and ED with our MangoRx 60-second short film competition.”
“Our partnership with Raindance Film Festival brings attention to issues surrounding men’s physical and mental health through award-winning storytelling,” said MangoRx CEO Jacob Cohen.